Placebo comparator group selection and use in surgical trials: the ASPIRE project including expert workshop

David Beard(Royal College of Surgeons of England), Jonathan Cook(Nuffield Orthopaedic Centre)

Health Technology Assessment

September 1, 2021

10.3310/hta25530

Cited by 8

Related Papers

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study

|Journal of Hepatology|2020|525

Arthroscopic subacromial decompression for subacromial shoulder pain (CSAW): a multicentre, pragmatic, parallel group, placebo-controlled, three-group, randomised surgical trial

|The Lancet|2017|461

Is Percutaneous Drainage the New Gold Standard in the Management of Emphysematous Pyelonephritis? Evidence From a Systematic Review

|The Journal of Urology|2008|292

Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)

|BMJ Open|2022|7